These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 24474819
1. Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. Xie Y, Fung HY, Newberry EP, Kennedy S, Luo J, Crooke RM, Graham MJ, Davidson NO. J Lipid Res; 2014 Mar; 55(3):540-8. PubMed ID: 24474819 [Abstract] [Full Text] [Related]
2. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice. Wang HH, Li X, Patel SB, Wang DQ. Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967 [Abstract] [Full Text] [Related]
4. Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice. Xie Y, Newberry EP, Kennedy SM, Luo J, Davidson NO. J Lipid Res; 2009 May; 50(5):977-87. PubMed ID: 19136665 [Abstract] [Full Text] [Related]
5. FMO3 and its metabolite TMAO contribute to the formation of gallstones. Chen Y, Weng Z, Liu Q, Shao W, Guo W, Chen C, Jiao L, Wang Q, Lu Q, Sun H, Gu A, Hu H, Jiang Z. Biochim Biophys Acta Mol Basis Dis; 2019 Oct 01; 1865(10):2576-2585. PubMed ID: 31251986 [Abstract] [Full Text] [Related]
6. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones. Amigo L, Castro J, Miquel JF, Zanlungo S, Young S, Nervi F. Gastroenterology; 2006 Dec 01; 131(6):1870-8. PubMed ID: 17064699 [Abstract] [Full Text] [Related]
7. Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited. Basso F, Freeman LA, Ko C, Joyce C, Amar MJ, Shamburek RD, Tansey T, Thomas F, Wu J, Paigen B, Remaley AT, Santamarina-Fojo S, Brewer HB. J Lipid Res; 2007 Jan 01; 48(1):114-26. PubMed ID: 17060690 [Abstract] [Full Text] [Related]
8. Ablating L-FABP in SCP-2/SCP-x null mice impairs bile acid metabolism and biliary HDL-cholesterol secretion. Martin GG, Atshaves BP, Landrock KK, Landrock D, Storey SM, Howles PN, Kier AB, Schroeder F. Am J Physiol Gastrointest Liver Physiol; 2014 Dec 01; 307(11):G1130-43. PubMed ID: 25277800 [Abstract] [Full Text] [Related]
12. Piperine prevents cholesterol gallstones formation in mice. Song XY, Xu S, Hu JF, Tang J, Chu SF, Liu H, Han N, Li JW, Zhang DM, Li YT, Chen NH. Eur J Pharmacol; 2015 Mar 15; 751():112-7. PubMed ID: 25645812 [Abstract] [Full Text] [Related]
14. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids. Kube I, Tardio LB, Hofmann U, Ghallab A, Hengstler JG, Führer D, Zwanziger D. Thyroid; 2021 Jun 15; 31(6):973-984. PubMed ID: 33231505 [Abstract] [Full Text] [Related]
17. Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Wang HH, Wang DQ. Hepatology; 2005 Oct 15; 42(4):894-904. PubMed ID: 16175613 [Abstract] [Full Text] [Related]
18. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models. Fan N, Meng K, Zhang Y, Hu Y, Li D, Gao Q, Wang J, Li Y, Wu S, Cui Y. Lipids Health Dis; 2020 Jul 02; 19(1):158. PubMed ID: 32615989 [Abstract] [Full Text] [Related]
19. Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion. Newberry EP, Molitor EA, Liu A, Chong K, Liu X, Alonso C, Mato JM, Davidson NO. Am J Pathol; 2024 Jun 02; 194(6):958-974. PubMed ID: 38417694 [Abstract] [Full Text] [Related]